Zhangzhou Pientzehuang Pharmaceutical., Ltd Stock Forecast for 2023 - 2025 - 2030
Updated on 05/08/2024
Zhangzhou Pientzehuang Pharmaceutical., Ltd Stock Forecast and Price Target
Year-long price target forecasts from two prominent analysts have recently been released for Zhangzhou Pientzehuang Pharmaceutical., Ltd, with an average price target of ¥282.55. This potential gain of 16.29 percent from the previous closing price in May, 2024 is calculated on a high forecast of ¥336.00 and a low estimate of ¥190.00. Although you may not be interested in 600436 stock, you should still be aware of its competitors.
16.29% Upside
Zhangzhou Pientzehuang Pharmaceutical., Ltd Fair Value Forecast for 2023 - 2025 - 2030
Zhangzhou Pientzehuang Pharmaceutical., Ltd's Price has decreased by 100.00% In the last four years, from ¥177.18 to ¥0.00. Analysts predict that Zhangzhou Pientzehuang Pharmaceutical., Ltd's Fair Value will increase in the upcoming year, reaching ¥412.98. This would represent an increase of 100.00%. Over the next seven years, experts predict that Zhangzhou Pientzehuang Pharmaceutical., Ltd's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 600276 Stock Forecast | Jiangsu Hengrui Medicine | Buy |
15
|
¥47.23 | Buy/Sell | ¥56.49 | 14.33% |
| T14 Stock Forecast | Tianjin Pharmaceutical Da Ren ... | Outperform |
18
|
$35.49 | Buy/Sell | $1.70 | 29.05% |
| 000538 Stock Forecast | Yunnan Baiyao Group Co.,Ltd | Outperform |
18
|
¥56.98 | Buy/Sell | ¥65.39 | 13.79% |
| 1093 Stock Forecast | CSPC Pharmaceutical Group | Buy |
18
|
HK$6.66 | Buy/Sell | HK$9.50 | 39.64% |
| 000999 Stock Forecast | China Resources Sanjiu Medical... | Buy |
18
|
¥60.35 | Buy/Sell | ¥65.95 | 12.91% |
Zhangzhou Pientzehuang Pharmaceutical., Ltd Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Zhangzhou Pientzehuang Pharmaceutical., Ltd's Revenue has seen an increase, rising from ¥6.51B to ¥10.03B. This represents a growth of 54.12%. Analysts predict that Zhangzhou Pientzehuang Pharmaceutical., Ltd's Revenue will increase in the upcoming year, reaching ¥11.88B. This would represent an increase of 18.40%. Over the next seven years, experts predict that Zhangzhou Pientzehuang Pharmaceutical., Ltd's Revenue will grow at a rate of 172.41%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 600085 Stock Forecast | Beijing Tongrentang | Outperform |
16
|
¥44.93 | Buy/Sell | ¥61.18 | 20.19% |
| 600196 Stock Forecast | Shanghai Fosun Pharmaceutical ... | Outperform |
16
|
¥24.19 | Buy/Sell | ¥33.57 | 7.90% |
| 002294 Stock Forecast | Shenzhen Salubris Pharmaceutic... | Buy |
18
|
¥31.49 | Buy/Sell | ¥35.65 | 17.50% |
.jpg)
Zhangzhou Pientzehuang Pharmaceutical., Ltd Dividend per Share Forecast for 2023 - 2025 - 2030
Zhangzhou Pientzehuang Pharmaceutical., Ltd's Dividend per Share has seen growth In the last two years, going from ¥0.90 to ¥1.25 – a gain of 38.89% In the next year, analysts believe that Dividend per Share will reach ¥1.81 – an increase of 44.80%. For the next seven years, the forecast is forDividend per Share to grow by 87.19%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 600079 Stock Forecast | Humanwell Healthcare (Group) | Buy |
0
|
¥20.32 | Buy/Sell | ¥32.49 | -48.13% |
| 000513 Stock Forecast | Livzon Pharmaceutical Group | Outperform |
18
|
¥36.98 | Buy/Sell | ¥39.23 | 11.41% |
| 600518 Stock Forecast | Kangmei Pharmaceutical | - |
6
|
¥1.97 | Buy/Sell | ¥25.97 | -100.00% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 300146 Stock Forecast | Byhealth | Outperform |
15
|
¥16.04 | Buy/Sell | ¥26.39 | 27.81% |
| 002262 Stock Forecast | Jiangsu Nhwa Pharmaceutical Co... | Buy |
18
|
¥25.25 | Buy/Sell | ¥31.34 | 22.77% |
| 900904 Stock Forecast | Shanghai Shenqi Pharmaceutical... | - |
13
|
$6.74 | Buy/Sell | $0.00 | -100.00% |
Zhangzhou Pientzehuang Pharmaceutical., Ltd EBITDA Forecast for 2023 - 2025 - 2030
Zhangzhou Pientzehuang Pharmaceutical., Ltd's EBITDA has grown in the last three years, jumping from ¥1.88B to ¥3.44B – an increase of 82.79%. In the next year, analysts predict that EBITDA will reach ¥4.33B – an increase of 25.80%. For the next seven years, the forecast is for EBITDA to grow by 39.81%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 600062 Stock Forecast | China Resources Double-Crane P... | Buy |
16
|
¥23.11 | Buy/Sell | ¥26.00 | 11.38% |
| 600380 Stock Forecast | Joincare Pharmaceutical Group ... | Buy |
18
|
¥11.61 | Buy/Sell | ¥14.72 | 26.79% |
| 002773 Stock Forecast | Chengdu Kanghong Pharmaceutica... | Buy |
11
|
¥23.88 | Buy/Sell | ¥24.00 | -100.00% |
Zhangzhou Pientzehuang Pharmaceutical., Ltd EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Zhangzhou Pientzehuang Pharmaceutical., Ltd's EBIT has increased by 89.35%, going from ¥1.79B to ¥3.39B. In the next year, analysts are expecting an increase in EBIT, predicting it will reach ¥4.33B – an increase of 27.56%. The Zhangzhou Pientzehuang Pharmaceutical., Ltd forecast is for EBIT to reach ¥8.28B or grow by 144.06%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 600867 Stock Forecast | Tonghua Dongbao Pharmaceutical | Buy |
18
|
¥10.38 | Buy/Sell | ¥14.25 | 36.99% |
| 603858 Stock Forecast | Shandong Buchang Pharmaceutica... | - |
18
|
¥16.85 | Buy/Sell | ¥0.00 | -100.00% |
| 000623 Stock Forecast | Jilin Aodong Pharmaceutical Gr... | Buy |
16
|
¥15.28 | Buy/Sell | ¥0.00 | 48.36% |
Zhangzhou Pientzehuang Pharmaceutical., Ltd EPS Price Prediction Forecast for 2023 - 2025 - 2030
Zhangzhou Pientzehuang Pharmaceutical., Ltd's EPS has decreased by 100.00% In the last four years, from ¥2.63 to ¥0.00. Analysts predict that Zhangzhou Pientzehuang Pharmaceutical., Ltd's EPS will increase in the upcoming year, reaching ¥6.13. This would represent an increase of 100.00%. Over the next seven years, experts predict that Zhangzhou Pientzehuang Pharmaceutical., Ltd's EPS will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 600422 Stock Forecast | KPC Pharmaceuticals,Inc | Buy |
18
|
¥23.78 | Buy/Sell | ¥28.00 | 5.17% |
| 000766 Stock Forecast | Tonghua Golden-Horse Pharmaceu... | - |
11
|
¥17.56 | Buy/Sell | ¥33.00 | -100.00% |
| 002019 Stock Forecast | Yifan Pharmaceutical | Buy |
16
|
¥14.10 | Buy/Sell | ¥16.42 | 34.75% |
Site Navigation
.jpg)